News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Biogen
NEWS
JOBS
IN THE PRESS
NEWS
Biotech Beach
Why Amgen, Biogen and Celgene are the Best Biotech Stocks Now
October 11, 2016
·
2 min read
Genetown
Celgene Could Dethrone Biogen in Multiple Sclerosis
September 29, 2016
·
1 min read
Deals
This Little Biotech Could be a New Acquisition Target for Allergan and Biogen
September 21, 2016
·
3 min read
Drug Development
Will Biogen’s Alzheimer’s Drug Be a Miracle Drug or Just Another Bomb?
September 20, 2016
·
3 min read
Business
Advice for Biogen: Take a Page Out of Biotech’s Best Friend Celgene’s Playbook
September 9, 2016
·
3 min read
Deals
Is Biogen Even Buyout Worthy?
September 6, 2016
·
3 min read
Deals
Allergan’s Brent Saunders Denies Interest in Biogen or Big M&A
August 10, 2016
·
3 min read
Business
Biogen Unveils Name for New Standalone Hemophilia-Focused Company: Bioverativ
August 9, 2016
·
3 min read
Deals
Biogen Not Pursuing an Acquisition, Says Source
August 4, 2016
·
3 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Ionis completes enrollment in pivotal cohort of the Phase 3 REVEAL study evaluating obudanersen in Angelman syndrome
July 6, 2026
·
6 min read
Press Releases
Samsung Bioepis Relaunches BYOOVIZ® (ranibizumab-nuna) in the United States in Partnership with Harrow
July 1, 2026
·
8 min read
Press Releases
Biogen to Highlight Breadth of Alzheimer’s Disease Portfolio at AAIC 2026, Including Phase 2 CELIA Data for Diranersen
June 29, 2026
·
13 min read
Press Releases
Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.
June 18, 2026
·
8 min read
Press Releases
New Progress Toward Public Reimbursement of SKYCLARYS™ for People Living with Friedreich Ataxia in Quebec
June 8, 2026
·
4 min read
Press Releases
FNIH Names Recipients of the 2026 Charles A. Sanders, MD, Partnership Award
June 4, 2026
·
3 min read
Press Releases
Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
June 4, 2026
·
13 min read
Press Releases
EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus
June 4, 2026
·
18 min read
Press Releases
Biogen Announces Upcoming Kidney Presentations at European Renal Association and American Transplant Congresses
June 3, 2026
·
20 min read
Press Releases
UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus
June 1, 2026
·
16 min read
